Price Alert

Hims & Hers Health Inc. (HIMS)

NYSE: HIMS · Real-Time Price · USD

44.15

0.14 (0.32%)

At close: Aug 28, 2025, 3:59 PM

44.33

0.41%

After-hours: Aug 28, 2025, 07:59 PM EDT

0.32% (1D)

Bid	44
Market Cap	9.61B
Revenue (ttm)	2.01B
Net Income (ttm)	193.6M
EPS (ttm)	0.79
PE Ratio (ttm)	55.89
Forward PE	57.43
Analyst	Hold

Ask	44.24
Volume	17,002,120
Avg. Volume (20D)	38,525,931
Open	44.45
Previous Close	44.01
Day's Range	43.80 - 45.10
52-Week Range	13.47 - 72.98
Beta	2.09

About HIMS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HIMS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HIMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Hims & Hers Health Inc. is scheduled to release its earnings on Nov 3, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-6.47%

Hims & Hers Health shares are trading lower after ... Unlock content with Pro Subscription

2 weeks ago

-2.48%

Hims & Hers Health shares are trading lower amid reports that the FTC is probing complaints about the company's ads and cancellation practices.

News

18 hours ago · zacks.com

HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?

Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.

1 day ago · zacks.com

Hims & Hers Scales Growth Through Subscriptions and Care Expansion

HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.

4 days ago · benzinga.com

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire

Wall Street's most crowded shorts are starting to look like powder kegs. Rocket Companies Inc RKT, Oscar Health Inc OSCR, and Hims & Hers Health Inc HIMS are sitting at the top of the market's short-i...

3 days ago · businesswire.com

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

NEW YORK--(BUSINESS WIRE)---- $HIMS #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Compa...

6 days ago · businesswire.com

HIMS & HERS HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25...

6 days ago · seekingalpha.com

Hims & Hers: Personalized Care To Sustain Revenue Growth Despite GLP-1 Hiccup

I remain bullish on Hims & Hers Health due to its resilient subscriber growth and strong positioning in the expanding personalized care and telehealth markets. Despite the loss of the GLP-1 contract w...

6 days ago · zacks.com

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

1 week ago · fool.com

Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term

The technology sector can be one of the best places to invest your money. With the digitalization trend gaining popularity and the rapid advancements taking place in artificial intelligence, the secto...

1 week ago · marketbeat.com

Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets

Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making this an area of interest for those looking into the next potential upswing in ...

1 week ago · seekingalpha.com

Here's How I Am Buying Hims & Hers At $37 Or Earning 4.2% Monthly Instead

Hims & Hers is undervalued, rapidly scaling a vertically integrated, consumer-focused healthcare platform with 73% YoY revenue growth and strong EBITDA margins. Market fears over GLP-1 regulatory chan...

Load More News